907479

Taro Pharmaceuticals U.S.A., Inc. — FEI 2435212

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 19, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hawthorne, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)